Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Johnson & Johnson is earmarking nearly $9 billion to cover allegations that its baby power containing talc caused cancer, more than quadrupling the amount that the company had previously set aside to pay for its potential liability.
The founder of the student loan assistance startup company Frank that J.P. Morgan Chase acquired for $175 million has been arrested on charges that she duped the financial giant.
President Joe Biden said Tuesday it remains to be seen if artificial intelligence is dangerous, but that he believes technology companies must ensure their products are safe before releasing them to the public.
